3M India sales rise 14.5% to ₹5,090 crore in FY26
3M India reported a 14.5% increase in sales to ₹5,090 crore for FY26, with PBT before exceptional items at ₹960 crore. PAT stood at ₹522 crore, while adjusted PAT excluding APA and VSV was ₹662 crore. The company's four business groups drove growth, with Healthcare leading at 17.5%.
*this image is generated using AI for illustrative purposes only.
3M India reported a 14.5% increase in sales to ₹5,090 crore for the financial year 2025-26. The company disclosed its financial performance during an analyst and institutional investors meeting held on May 27, 2026, in Mumbai. The presentation was submitted to the exchanges in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015.
Profit before tax (PBT) before exceptional items was ₹960 crore, representing 18.7% of sales and an increase of 1.6 percentage points year-over-year. After exceptional items, PBT stood at ₹894 crore, or 17.4% of sales. Profit after tax (PAT) was ₹522 crore, accounting for 10.2% of sales. Excluding prior year adjustments (APA) and very significant variances (VSV), PAT was ₹662 crore, or 12.9% of sales.
The company generated cash of ₹483 crore pre-dividend. Earnings per share (EPS) increased by 9.7% compared to the previous year to reach ₹463.66 per share. The exceptional items for the year included an APA of ₹139 crore and a VSV of ₹99 crore from the prior year.
Business Group Performance
Sales growth was driven by the company's four business groups. Transportation & Electronics reported sales of ₹1,846 crore with a 10.1% growth, holding a 36% sales mix. Safety & Industrial achieved sales of ₹1,640 crore, a 16% increase, with a 32% mix. Healthcare sales grew 17.5% to ₹1,017 crore, constituting 20% of the mix. The Consumer business recorded sales of ₹537 crore, a 15.6% increase, with an 11% mix.
Operational Highlights
3M India operates three manufacturing facilities, one R&D center, and two Customer Technical Centers. The company employed approximately 1,273 people. Management outlined strategies focusing on commercial excellence, local R&D capabilities, and strengthening the local supply chain to drive future growth.
| Metric | Value | Growth/Mix |
|---|---|---|
| Sales | ₹5,090 cr | +14.5% vs. PY |
| PBT (Before Exceptional) | ₹960 cr | 18.7% of Sales |
| PAT | ₹522 cr | 10.2% of Sales |
| EPS | ₹463.66/share | +9.7% vs. PY |
Historical Stock Returns for 3M India
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.24% | -2.29% | -0.41% | -8.50% | +7.59% | +20.64% |
How will 3M India's focus on local R&D capabilities impact its product pipeline and competitive edge in the coming years?
What are the expected growth drivers for the Healthcare and Safety & Industrial segments given their strong performance this year?
How will the company manage exceptional items and prior year adjustments to stabilize profitability in future financial years?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
